HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Influence of chronic renal failure and of its treatment on serum erythropoietin].

AbstractBACKGROUND:
In order to know the influence of dialysis treatment in erythropoietin production, serum erythropoietin (Ep) has been studied in patients with anemia due to chronic renal failure (CRF).
METHODS:
Thirty six of them in hemodialysis (HD), 10 in continuous ambulatory peritoneal dialysis (CAPD) and 18 in predialysis stage (PD) and their results were compared to two control groups, including 72 healthy controls (HC) and the second one 89 iron deficiency anemia patients (ID).
RESULTS:
Patients had lower Hb and Ep levels than the other groups. Although Ep was higher in CAPD and PD. Ep levels were similar to HC values, and lower than ID levels. It could be demonstrated any correlation between Hb and Ep in CRF patients, however a negative exponential correlation was demonstrated in ID patients between Hb and Ep (r = -0.83; p less than 0.00001). In summary, Ep is higher in CAPD and in PD than in HD, but the levels are lower than they should be expected.
CONCLUSIONS:
These data confirm an Ep production failure in most of IRC patients and it seems likely that Ep treatment could be effective to treat the anemia of CRF.
AuthorsA F Remacha, A Oliver, F Calero, M J Barceló, T Doñate, J A Ballarín, F García-Die
JournalMedicina clinica (Med Clin (Barc)) Vol. 99 Issue 4 Pg. 125-7 (Jun 20 1992) ISSN: 0025-7753 [Print] Spain
Vernacular TitleInfluencia de la insuficiencia renal crónica y de su tratamiento en la eritropoyetina sérica.
PMID1635404 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Erythropoietin
Topics
  • Anemia (blood, etiology)
  • Erythropoietin (blood)
  • Female
  • Humans
  • Kidney Failure, Chronic (blood, therapy)
  • Male
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: